G. Rizzardi

发表

2D TR-NOESY experiments interrogate and rank ligand-receptor interactions in living human cancer cells.

A. Spitaleri, M. Ghitti, G. Musco, 2010, Angewandte Chemie.

Evolutionary pattern of human immunodeficiency virus (HIV) replication and distribution in lymph nodes following primary infection: Implications for antiviral therapy

C. Fox, A. Fauci, G. Pantaleo, 1998, Nature Medicine.

Phase II study of NGR-hTNF, a selective vascular targeting agent, in patients with metastatic colorectal cancer after failure of standard therapy.

A. Santoro, L. Rimassa, M. Tronconi, 2010, European journal of cancer.

Critical Role of Flanking Residues in NGR-to-isoDGR Transition and CD13/Integrin Receptor Switching*

R. Longhi, A. Corti, F. Curnis, 2010, The Journal of Biological Chemistry.

Independent evolution of hypervariable regions of HIV-1 gp120: V4 as a swarm of N-Linked glycosylation variants.

G. Pantaleo, P. Bart, C. Graziosi, 2008, AIDS research and human retroviruses.

Shorter survival of SDF1-3'A/3'A homozygotes linked to CD4+ T cell decrease in advanced human immunodeficiency virus type 1 infection.

G. Pantaleo, A. Lazzarin, H. Sheppard, 2000, The Journal of infectious diseases.

Shorter Survival of SDF 1-3 ′ A / 3 ′ A Homozygotes Linked to CD 4 + T Cell Decrease in Advanced Human Immunodeficiency Virus Type 1 Infection

G. Pantaleo, A. Lazzarin, H. Sheppard, 2022 .

The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4+ T lymphocytes and CD34+-derived macrophages by blocking HIV-1 DNA integration.

F. Gubinelli, C. Bovolenta, R. Lupo, 2009, Blood.

Soluble CD30, tumour necrosis factor (TNF)-alpha, and TNF receptors in primary HIV-1 infection: relationship with HIV-1, RNA, clinical outcome and early antiviral therapy.

G. Pantaleo, A. Lazzarin, W. Barcellini, 1997, Journal of Biological Regulators and Homeostatic Agents.

β-Endorphin content in HIV-infected HuT78 cell line and in peripheral lymphocytes from HIV-positive subjects

A. Lazzarin, P. Sacerdote, P. Meroni, 1994, Peptides.

NGR and isoDGR are separate moieties binding to different receptors.

C. Bordignon, G. Rizzardi, 2009, Blood.

Critical role of indoleamine 2,3-dioxygenase in tumor resistance to repeated treatments with targeted IFNγ

A. Corti, F. Curnis, A. Gasparri, 2008, Molecular Cancer Therapeutics.

CCR2 polymorphism and HIV disease. Swiss HIV Cohort.

G. Pantaleo, A. Lazzarin, E. Vicenzi, 1998, Nature medicine.

Engagement of adhesion molecules (CD18, CD11a, CD45, CD44, and CD58) enhances human immunodeficiency virus type 1 replication in monocytic cells through a tumor necrosis factor-modulated pathway.

R. Shattock, G. Griffin, P. Hayes, 1996, The Journal of infectious diseases.

The F12-Vif derivative Chim3 inhibits HIV-1 replication in CD4 (cid:1) T lymphocytes and CD34 (cid:1) -derived macrophages by blocking HIV-1 DNA integration

F. Gubinelli, C. Bovolenta, R. Lupo, 2009 .

The tumor vessel targeting agent NGR-TNF controls the different stages of the tumorigenic process in transgenic mice by distinct mechanisms

B. Valentinis, C. Bordignon, C. Traversari, 2015, Oncoimmunology.

Risks and benefits of aerosolized pentamidine and cotrimoxazole in primary prophylaxis of Pneumocystis carinii pneumonia in HIV-1-infected patients: a two-year Italian multicentric randomized controlled trial

M. Moroni, A. Lazzarin, M. Musicco, 1996 .

Immunomodulatory effects of occupational exposure to mancozeb.

D. Cavallo, P. Meroni, L. Soleo, 1996, Archives of environmental health.

Increased expression of IgG Fc receptor type I on neutrophils and monocytes from HIV‐infected subjects

C. Zanussi, G. Rizzardi, F. Capsoni, 1992, Clinical and experimental immunology.

Membrane Expression and Function of Complement Receptors CR1 and CR3 on Neutrophils from HIV‐Infected Subjects: Modulation by rTNF‐α and rGM‐CSF

A. Lazzarin, C. Zanussi, G. Rizzardi, 1992, Scandinavian journal of immunology.

Monocyte-derived macrophage function in HIV-infected subjects: in vitro modulation by rIFN-gamma and rGM-CSF.

A. Lazzarin, C. Zanussi, G. Rizzardi, 1992, Clinical immunology and immunopathology.

RD2-MolPack-Chim3, a packaging cell line for stable production of lentiviral vectors for anti-HIV gene therapy.

C. Bordignon, F. Mavilio, C. Bovolenta, 2013, Human gene therapy methods.

Chim3 confers survival advantage to CD4+ T cells upon HIV-1 infection by preventing HIV-1 DNA integration and HIV-1-induced G2 cell-cycle delay.

F. Gubinelli, C. Bovolenta, L. Alberici, 2010, Blood.

TH1 and TH2 cytokine production by peripheral blood mononuclear cells from HIV‐infected patients

A. Lazzarin, P. Meroni, W. Barcellini, 1994, AIDS.

Long-term kinetics of T cell production in HIV-infected subjects treated with highly active antiretroviral therapy.

G. Pantaleo, A. Lazzarin, J. Meuwly, 2000, Proceedings of the National Academy of Sciences of the United States of America.

Structural Basis for the Interaction of isoDGR with the RGD-binding Site of αvβ3 Integrin*

R. Longhi, A. Corti, F. Curnis, 2008, Journal of Biological Chemistry.

Predicting the duration of antiviral treatment needed to suppress plasma HIV-1 RNA.

C. Fox, L. Perrin, G. Pantaleo, 2000, The Journal of clinical investigation.

Effects of mycophenolic acid on human immunodeficiency virus infection in vitro and in vivo

G. Pantaleo, S. Fleury, Giuseppe Pantaleo, 2000, Nature Medicine.

Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection.

A. Telenti, D. Kaufmann, L. Perrin, 2002, Blood.

Immunological and virological responses in HIV-1-infected adults at early stage of established infection treated with highly active antiretroviral therapy

S. Yerly, L. Perrin, G. Pantaleo, 2000, AIDS.

NGR-TNF, a novel vascular-targeting agent, does not induce cytokine recruitment of proangiogenic bone marrow-derived cells

R. Kerbel, B. Valentinis, C. Bordignon, 2013, British Journal of Cancer.

Better efficacy of twice-monthly than monthly aerosolised pentamidine for secondary prophylaxis of Pneumocystis carinii pneumonia in patients with AIDS. An Italian multicentric randomised controlled trial. The Italian PCP Study Group.

M. Moroni, A. Lazzarin, D. Frigerio, 1995, The Journal of infection.

Vectofusin-1 Promotes RD114-TR-Pseudotyped Lentiviral Vector Transduction of Human HSPCs and T Lymphocytes

A. Galy, C. Bordignon, C. Bovolenta, 2017, Molecular therapy. Methods & clinical development.

Codon Optimization Leads to Functional Impairment of RD114-TR Envelope Glycoprotein

M. Pema, C. Bordignon, C. Bovolenta, 2017, Molecular therapy. Methods & clinical development.

RD-MolPack technology for the constitutive production of self-inactivating lentiviral vectors pseudotyped with the nontoxic RD114-TR envelope

M. Pema, C. Bordignon, C. Bovolenta, 2016, Molecular therapy. Methods & clinical development.

Determination of Interference During In Vitro Pyrogen Detection: Development and Characterization of a Cell-Based Assay.

M. Magnani, S. Dominici, M. Rocchi, 2017, Assay and drug development technologies.

Effects of CCR5- 32, CCR2-64I, and SDF-1 3A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data

H. Ullum, J. Goedert, J. Ioannidis, 2001, Annals of Internal Medicine.

Skewed maturation of memory HIV-specific CD8 T lymphocytes

S. Rowland-Jones, G. Pantaleo, V. Appay, 2001, Nature.

Initiation of Antiretroviral Therapy during Primary Hiv-1 Infection Induces Rapid Stabilization of the T-cell Receptor ␤ Chain Repertoire and Reduces the Level of T-cell Oligoclonality

D. Kaufmann, G. Pantaleo, A. Lazzarin, 2022 .

Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A alleles on HIV-1 disease progression: An international meta-analysis of individual-patient data.

H. Ullum, J. Goedert, J. Ioannidis, 2001, Annals of internal medicine.

Immunopathogenesis of HIV infection.

G. Pantaleo, G Pantaleo, H Soudeyns, 1998, AIDS research and human retroviruses.

CCR2 Polymorphism and HIV Disease

G. Pantaleo, A. Lazzarin, E. Vicenzi, 1998, Nature Medicine.

Effects of CCR5-Δ32 and CCR2-64I alleles on HIV-1 disease progression: the protection varies with duration of infection

J. Goedert, J. Ioannidis, D. Vlahov, 2003, AIDS.

Effect of Antiretroviral Therapy on Apoptosis Markers and Morphology in Peripheral Lymph Nodes of HIV-Infected Individuals

F. Gudat, M. Battegay, G. Pantaleo, 2008, Infection.

Allogeneic murine melanoma cell vaccine: a model for the development of human allogeneic cancer vaccine

S. Ball, A. Dalgleish, B. Souberbielle, 1996, Melanoma research.

Molecular dynamics reveal that isoDGR-containing cyclopeptides are true αvβ3 antagonists unable to promote integrin allostery and activation.

Silvia Mari, Michela Ghitti, Andrea Spitaleri, 2012, Angewandte Chemie.

Enhanced Expression of CD13 in Vessels of Inflammatory and Neoplastic Tissues

C. Doglioni, A. Corti, P. Matteo, 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Isoaspartate-glycine-arginine: a new tumor vasculature-targeting motif.

R. Longhi, C. Doglioni, A. Corti, 2008, Cancer research.

Genetic polymorphism of CCR5 gene and HIV disease: The heterozygous (CCR5/Δccr5) genotype is neither essential nor sufficient for protection against disease progression

L. Perrin, B. Hirschel, A. Lazzarin, 1997 .

Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy.

Adriano Lazzarin, Patrick Champagne, G. Pantaleo, 2002, The Journal of clinical investigation.

Limited CD4+ T-cell renewal in early HIV-1 infection: Effect of highly active antiretroviral therapy

P. Schnyder, G. Pantaleo, F. Miedema, 1998, Nature Medicine.

Use of metadynamics in the design of isoDGR-based αvβ3 antagonists to fine-tune the conformational ensemble.

A. Spitaleri, M. Ghitti, G. Musco, 2011, Angewandte Chemie.

The effect of cytokines on human neutrophil Fc receptor-mediated phagocytosis.

C. Zanussi, G. Rizzardi, F. Capsoni, 1991, Journal of clinical & laboratory immunology.

Acute pancreatitis during primary HIV-1 infection.

A. Lazzarin, G. Rizzardi, G. Tambussi, 1997, The New England journal of medicine.

Virological and immunological responses to HAART in asymptomatic therapy-naive HIV-1-infected subjects according to CD4 cell count

G. Pantaleo, A. Lazzarin, G. Tambussi, 2000, AIDS.

Anti-metastatic activity of the tumor vascular targeting agent NGR-TNF

C. Doglioni, B. Valentinis, P. Matteo, 2015, Clinical & Experimental Metastasis.

De novo design of a tumor-penetrating peptide.

Erkki Ruoslahti, Tambet Teesalu, E. Ruoslahti, 2013, Cancer research.

Pathogenesis of HIV-1 Infection

G. Pantaleo, G. Rizzardi, 2019, Chemokine Receptors and AIDS.

Mechanism of Action of the Tumor Vessel Targeting Agent NGR-hTNF: Role of Both NGR Peptide and hTNF in Cell Binding and Signaling

M. Degano, G. Musco, B. Valentinis, 2019, International journal of molecular sciences.

Cytokines and soluble receptor changes in the transition from primary to early chronic HIV type 1 infection.

A. Lazzarin, P. Meroni, G. Poli, 1996, AIDS research and human retroviruses.

In vitro production of type 1 and type 2 cytokines by peripheral blood mononuclear cells from high‐risk HIV‐negative intravenous drug users

A. Lazzarin, P. Meroni, M. Borghi, 1995, AIDS.

Potential role of immune modulation in the effective long-term control of HIV-1 infection.

G. Pantaleo, A. Lazzarin, G. Rizzardi, 2002, Journal of biological regulators and homeostatic agents.

Anti-metastatic activity of the tumor vascular targeting agent NGR-TNF

C. Doglioni, B. Valentinis, P. Matteo, 2015, Clinical & Experimental Metastasis.

Initiation of antiretroviral therapy during primary HIV-1 infection induces rapid stabilization of the T-cell receptor beta chain repertoire and reduces the level of T-cell oligoclonality.

G. Tambussi, J. Demarest, G. Rizzardi, 2000, Blood.

Use of metadynamics in the design of isoDGR-based αvβ3 antagonists to fine-tune the conformational ensemble.

A. Spitaleri, G. Musco, C. Traversari, 2011, Angewandte Chemie.

Enhanced Expression of CD13 in Vessels of Inflammatory and Neoplastic Tissues

C. Doglioni, A. Corti, P. Matteo, 2010, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

Interleukin-10-induced HIV-1 expression is mediated by induction of both membrane-bound tumour necrosis factor (TNF)-alpha and TNF receptor type 1 in a promonocytic cell line.

P. Meroni, R. Shattock, G. Poli, 1996, AIDS.

540. Vectofusin-1 Significantly Enhances Transduction of Ex-Vivo Activated T Cells With RD114-TR-Pseudotyped Lentiviral Vectors Derived from the RD3-MolPack Stable Packaging Cells

A. Galy, C. Bordignon, C. Bovolenta, 2015 .

De novo design of a tumor-penetrating peptide.

E. Ruoslahti, K. Sugahara, T. Teesalu, 2013, Cancer research.

Molecular dynamics reveal that isoDGR-containing cyclopeptides are true αvβ3 antagonists unable to promote integrin allostery and activation.

A. Spitaleri, G. Musco, B. Valentinis, 2012, Angewandte Chemie.

Cyclosporin A in combination with HAART in primary HIV-1 infection.

G. Pantaleo, A. Lazzarin, M. Vaccarezza, 2000, Journal of biological regulators and homeostatic agents.